{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:33:11Z","timestamp":1790271191433,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jasc.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:41:48Z","timestamp":1600429308000},"page":"155-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of a genomic classifier on indeterminate thyroid nodules: an institutional experience"],"prefix":"10.1016","volume":"10","author":[{"given":"Dina A.","family":"Abdelhakam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0298-881X","authenticated-orcid":false,"given":"Rafael E.","family":"Mojica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Huenerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6678-9329","authenticated-orcid":false,"given":"Aziza","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2020.09.005_bib1","volume":"2019","year":"2019"},{"key":"10.1016\/j.jasc.2020.09.005_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2020.09.005_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339959","article-title":"The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis","volume":"56","author":"Bongiovanni","year":"2012","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2020.09.005_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda System for Reporting Thyroid Cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2020.09.005_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12022-011-9182-7","article-title":"Update in thyroid fine needle aspiration","volume":"22","author":"Faquin","year":"2011","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.jasc.2020.09.005_bib6","doi-asserted-by":"crossref","first-page":"E1852","DOI":"10.1210\/jc.2013-2292","article-title":"Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer","volume":"98","author":"Nikiforova","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jasc.2020.09.005_bib7","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1614265114","article-title":"THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer","volume":"114","author":"Panebianco","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jasc.2020.09.005_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jasc.2020.09.005_bib9","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/cncr.31245","article-title":"Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules","volume":"124","author":"Nikiforova","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2020.09.005_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jc.2013-2482","article-title":"Multicenter clinical experience with the Afirma gene expression classifier","volume":"99","author":"Alexander","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jasc.2020.09.005_bib11","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2015-1158","article-title":"Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology","volume":"100","author":"Labourier","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jasc.2020.09.005_bib12","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1002\/cncr.29038","article-title":"Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm\/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay","volume":"120","author":"Nikiforov","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2020.09.005_bib13","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jasc.2020.09.005_bib14","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1073\/pnas.1321937111","article-title":"Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer","volume":"111","author":"Kelly","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jasc.2020.09.005_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/dc.10043","article-title":"Diagnosis of \"follicular neoplasm\": a gray zone in thyroid fine-needle aspiration cytology","volume":"26","author":"Baloch","year":"2002","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.09.005_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jasc.2020.09.005_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1210\/jc.2009-2103","article-title":"Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology","volume":"95","author":"Cantara","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jasc.2020.09.005_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cncy.20063","article-title":"Contribution of molecular testing to thyroid fine-needle aspiration cytology of \"follicular lesion of undetermined significance\/atypia of undetermined significance","volume":"118","author":"Ohori","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.09.005_bib19","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1089\/thy.2015.0305","article-title":"Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance\/follicular lesion of undetermined significance cytology","volume":"25","author":"Nikiforov","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2020.09.005_bib20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.7150\/jca.13898","article-title":"MicroRNA expression profiles in papillary thyroid carcinoma, benign thyroid nodules and healthy controls","volume":"7","author":"Yoruker","year":"2016","journal-title":"J Cancer"},{"key":"10.1016\/j.jasc.2020.09.005_bib21","first-page":"3359","article-title":"Gene expression differences between thyroid carcinoma, thyroid adenoma and normal thyroid tissue","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jasc.2020.09.005_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jasc.2020.09.005_bib23","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2002-021907","article-title":"RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jasc.2020.09.005_bib24","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1038\/sj.onc.1207980","article-title":"Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer","volume":"23","author":"Frattini","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jasc.2020.09.005_bib25","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jasc.2020.09.005_bib26","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/sj.onc.1206706","article-title":"BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC","volume":"22","author":"Soares","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jasc.2020.09.005_bib27","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/mend-4-10-1474","article-title":"Point mutations of ras oncogenes are an early event in thyroid tumorigenesis","volume":"4","author":"Namba","year":"1990","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jasc.2020.09.005_bib28","first-page":"565","article-title":"Presence of mutations in all three ras genes in human thyroid tumors","volume":"5","author":"Suarez","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.jasc.2020.09.005_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/thy.1996.6.409","article-title":"Prevalence of activating ras mutations in morphologically characterized thyroid nodules","volume":"6","author":"Ezzat","year":"1996","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2020.09.005_bib30","volume":"2020","year":"2016"},{"key":"10.1016\/j.jasc.2020.09.005_bib31","series-title":"The Bethesda System for Reporting Thyroid Cytopathology : Definitions, Criteria, and Explanatory Notes","author":"Ali","year":"2018"},{"key":"10.1016\/j.jasc.2020.09.005_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/dc.23915","article-title":"Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations","volume":"46","author":"Mon","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.09.005_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/cyt.12493","article-title":"Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy","volume":"28","author":"Decaussin-Petrucci","year":"2017","journal-title":"Cytopathology"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520303082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520303082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:46:23Z","timestamp":1761979583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294520303082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2213294520303082"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2020.09.005","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a genomic classifier on indeterminate thyroid nodules: an institutional experience","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}